How Sapropterin Reduces PKU Symptoms
Sapropterin dihydrochloride (Kuvan) is a synthetic form of tetrahydrobiopterin (BH4), a cofactor for phenylalanine hydroxylase (PAH). In phenylketonuria (PKU), PAH mutations impair conversion of phenylalanine (Phe) to tyrosine, causing toxic Phe buildup that damages the brain. Sapropterin restores partial PAH function in responsive patients—about 20-50% of those with milder PAH variants—lowering blood Phe levels and easing dietary restrictions.[1][2]
Patients typically see Phe reductions within hours to days, with full effects in 4 weeks. Doses of 10-20 mg/kg/day enable higher protein intake, improving growth, neurocognitive scores, and quality of life in children and adults.[3]
Which PKU Patients Respond Best?
Responsiveness depends on PAH genotype; those with mutations allowing residual enzyme activity (e.g., certain missense variants) benefit most. A 4-week therapeutic trial measures Phe drop: ≥30% indicates response. Non-responders, often with null mutations or severe classical PKU, see no benefit and rely on low-Phe diets.[1][4]
| Patient Group | Response Rate | Phe Reduction |
|---------------|---------------|---------------|
| Mild hyperphenylalaninemia | ~50% | 30-50% |
| Moderate PKU | ~30% | 20-40% |
| Classical PKU | <10% | Minimal |
What Symptom Improvements Are Seen?
- Blood Phe Control: Primary effect; sustained drops prevent intellectual disability, seizures, and behavioral issues from hyperphenylalaninemia.
- Neurocognitive Gains: Responsive kids show better IQ, attention, and executive function vs. diet-only controls.
- Nutritional Flexibility: Allows 20-130% more natural protein, reducing malnutrition risk and easing caregiver burden.
- No Cure: Doesn't fix underlying mutation; lifelong use needed, with monitoring for tolerance loss.[2][3]
Common Side Effects and Risks
Mostly mild: headache (12%), rhinitis (9%), pharyngitis. Rare serious risks include hypersensitivity (stop if rash/swelling) or Phe rebound upon discontinuation. Not for pregnant patients due to fetal harm potential.[1]
How It Fits with Diet and Alternatives
Sapropterin augments Phe-restricted diets but doesn't replace them. Combine with medical foods for best outcomes. Alternatives include pegvaliase (Palynziq, enzyme substitute for adults) or gene therapy trials. Cost: ~$100,000/year; patient assistance available.[5]
Sources
[1] Kuvan Prescribing Information (FDA)
[2] BioMarin Kuvan Overview
[3] NEJM Study on Sapropterin in PKU
[4] Genetics Home Reference - PKU
[5] DrugPatentWatch - Sapropterin Patents